Published by Josh White on 29th January 2025
(Sharecast News) - ValiRx announced on Wednesday that it has entered into an evaluation and option agreement with Canada-based Altus Formulation to assess the potential of Altus' SmartCelle drug delivery technology and novel anti-inflammatory compounds for cancer treatment.
URL: http://www.digitallook.com/dl/news/story/34844923/...